ONI
PrivateLast Round
Series B
Jan 20, 2022
Est. Valuation
$100M
Total Funding Raised
$105.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ONI is a biotechnology company that develops single-molecule super-resolution microscopes to enhance biological research by allowing researchers to visualize and analyze molecules and structures within living cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONI Comparables
Compare ONI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abberior Instruments | 82% | |
| Abbelight | 80% | |
| CSR Biotech | 78% |
ONI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 20, 2022 | ||||
| Grant | Jan 1, 2021 | ||||
| Series A | Jul 1, 2018 | ||||
| Seed | Apr 1, 2017 | ||||
| Seed | May 10, 2016 |
Key People
Founding team and executive leadership
ONI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| IP Group | Series A |
| Oxford Science Enterprises | Series B, Seed |
| ARCH Venture Partners | Series B |
| ARTIS Ventures | Series B |
| Axon Ventures | Series B |
| ARCH Venture Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 162% MoM, reaching 46.6K.
- Feb 24, 2026
Launched LNP PREP for sample-to-answer automation.
Recent news
Latest coverage and updates
- recognized_asSep 16, 2026
ONI recognized as one of this year's Health & Life Sciences Trailblazers on Sep 16th '26.
- recognized_asSep 16, 2026
ONI recognized as 2026 Health Trailblazer on Sep 16th '26.
ONI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ONI's valuation, stock price, and market status.
Is ONI a public or private company?
ONI is a private company.
What is the current stock price of ONI?
ONI is a private company with no public stock price. No recent secondary market data is available.
How much is ONI worth (valuation)?
ONI's valuation is estimated at $100.0M based on funding round data.
Can I buy ONI stock?
ONI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ONI's last funding round?
ONI's most recent funding round was Series B on July 1, 2018.
Who are the main investors in ONI?
Key investors in ONI include Oxford Science Enterprises, ARCH Venture Partners, Casdin Capital, European Union, Oxford Technology.
Will ONI IPO soon?
No public IPO plans have been announced for ONI.
How can I track ONI secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ONI's secondary market activity and sign up for updates.